American biotech company Moderna has announced on June 11 that it will start the final stage of a COVID-19 vaccine trial in July. (Photo Illustration by Jakub Porzycki/NurPhoto via Getty Images) LOS ANGELES - The Trump Administration, through the U.S.
Department of Health and Human Services (HHS) and Department of Defense (DoD), will purchase an additional 100 million doses of COVID-19 vaccine candidate from drugmaker Moderna, according to a new press release published Friday.“If authorized by the U.S.
Food and Drug Administration for emergency use as outlined in agency guidance, doses of the vaccine will begin shipping immediately,” the report said.This announcement would bring the total doses of Modern owned by the federal government to.